Cutler Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,900	Closed	-$33K	–	4384
2022 Q4	$33K	Buy	+4,900	New	+$574K	﹤0.01%	1866
2020 Q2	–	Sell	-5,000	Closed	-$2K	–	4700
2020 Q1	$2K	Hold	5,000	–	–	﹤0.01%	3516
2019 Q4	$3K	Buy	+5,000	New	+$524K	﹤0.01%	3297
2019 Q2	–	Sell	-6,000	Closed	-$47K	–	4604
2019 Q1	$47K	Buy	6,000 +100	+2%	+$8.36K	﹤0.01%	1475
2018 Q4	$18K	Buy	5,900 +900	+18%	+$86.2K	﹤0.01%	2180
2018 Q3	$44K	Sell	5,000 -16,400	-77%	-$1.86M	﹤0.01%	1688
2018 Q2	$170K	Sell	21,400 -1,100	-5%	-$98.5K	0.01%	855
2018 Q1	$78K	Buy	22,500 +16,000	+246%	+$1.35M	0.01%	1360
2017 Q4	$119K	Sell	6,500 -1,200	-16%	-$81.9K	﹤0.01%	1272
2017 Q3	$83K	Sell	7,700 -8,500	-52%	-$449K	﹤0.01%	1816
2017 Q2	$14K	Sell	16,200 -20,600	-56%	-$999K	﹤0.01%	3806
2017 Q1	$59K	Buy	36,800 +12,200	+50%	+$523K	﹤0.01%	2230
2016 Q4	$18K	Sell	24,600 -65,600	-73%	-$2.97M	﹤0.01%	3565
2016 Q3	$144K	Buy	90,200 +22,000	+32%	+$1.1M	0.01%	1496
2016 Q2	$147K	Buy	68,200 +53,800	+374%	+$2.48M	0.01%	1362
2016 Q1	$4K	Sell	14,400 -80,600	-85%	-$3.2M	﹤0.01%	5061
2015 Q4	$992K	Buy	+95,000	New	+$4.83M	0.06%	338